These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25705018)

  • 1. Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines.
    Stolze B; Reinhart S; Bulllinger L; Fröhling S; Scholl C
    Sci Rep; 2015 Feb; 5():8535. PubMed ID: 25705018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib.
    Gamba S; Camaj P; Heinemann V; Laubender RP; Wang Y; Zhao Y; Stintzing S; Giessen C; Boeck S; Haertl C; Bruns CJ; Modest DP
    Anticancer Drugs; 2015 Apr; 26(4):371-8. PubMed ID: 25514114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer.
    Modest DP; Camaj P; Heinemann V; Schwarz B; Jung A; Laubender RP; Gamba S; Haertl C; Stintzing S; Primo S; Bruns CJ
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):953-61. PubMed ID: 23455880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous oncogenic KRAS expression increases cell proliferation and motility in near-diploid hTERT RPE-1 cells.
    Hindul NL; Abbott LR; Adan SMD; Straatman KR; Fry AM; Hirota K; Tanaka K
    J Biol Chem; 2024 Jun; 300(6):107409. PubMed ID: 38796063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.
    Hammond DE; Mageean CJ; Rusilowicz EV; Wickenden JA; Clague MJ; Prior IA
    J Proteome Res; 2015 Mar; 14(3):1535-46. PubMed ID: 25599653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor and hepatocyte growth factor cooperate to enhance cell proliferation, scatter, and invasion in murine mammary epithelial cells.
    Accornero P; Miretti S; Starvaggi Cucuzza L; Martignani E; Baratta M
    J Mol Endocrinol; 2010 Feb; 44(2):115-25. PubMed ID: 19850646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic characterization of colorectal cancer cells harbouring different KRAS mutations in codon 12, 13, 61 and 146 using human SW48 isogenic cell lines.
    Varshavi D; Varshavi D; McCarthy N; Veselkov K; Keun HC; Everett JR
    Metabolomics; 2020 Apr; 16(4):51. PubMed ID: 32300895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model.
    Alamo P; Gallardo A; Di Nicolantonio F; Pavón MA; Casanova I; Trias M; Mangues MA; Lopez-Pousa A; Villaverde A; Vázquez E; Bardelli A; Céspedes MV; Mangues R
    FASEB J; 2015 Feb; 29(2):464-76. PubMed ID: 25359494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational analysis of KRAS mutations: implications for different effects on the KRAS p.G12D and p.G13D mutations.
    Chen CC; Er TK; Liu YY; Hwang JK; Barrio MJ; Rodrigo M; Garcia-Toro E; Herreros-Villanueva M
    PLoS One; 2013; 8(2):e55793. PubMed ID: 23437064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey.
    Park JT; Johnson N; Liu S; Levesque M; Wang YJ; Ho H; Huso D; Maitra A; Parsons MJ; Prescott JD; Leach SD
    Oncogene; 2015 May; 34(21):2801-6. PubMed ID: 25065594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.
    LeVea CM; Reeder JE; Mooney RA
    Exp Cell Res; 2004 Jul; 297(1):272-84. PubMed ID: 15194442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.
    Preto A; Figueiredo J; Velho S; Ribeiro AS; Soares P; Oliveira C; Seruca R
    J Pathol; 2008 Feb; 214(3):320-7. PubMed ID: 18098337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor and hepatocyte growth factor receptors collaborate to induce multiple biological responses in bovine mammary epithelial cells.
    Accornero P; Martignani E; Miretti S; Starvaggi Cucuzza L; Baratta M
    J Dairy Sci; 2009 Aug; 92(8):3667-75. PubMed ID: 19620648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
    Takezawa K; Okamoto I; Yonesaka K; Hatashita E; Yamada Y; Fukuoka M; Nakagawa K
    Cancer Res; 2009 Aug; 69(16):6515-21. PubMed ID: 19638574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
    Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
    Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes.
    Dajani OF; Meisdalen K; Guren TK; Aasrum M; Tveteraas IH; Lilleby P; Thoresen GH; Sandnes D; Christoffersen T
    J Cell Physiol; 2008 Feb; 214(2):371-80. PubMed ID: 17654493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
    Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
    Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation-Specific and Common Phosphotyrosine Signatures of
    Tahir R; Renuse S; Udainiya S; Madugundu AK; Cutler JA; Nirujogi RS; Na CH; Xu Y; Wu X; Pandey A
    J Proteome Res; 2021 Jan; 20(1):670-683. PubMed ID: 32986951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.